Summary
This prediction ended on 09.11.16 with a price of €91.18. The BUY prediction by Quitte finished with a performance of 3.17%. Quitte has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | 2.445% | 2.445% | -46.084% | -47.048% |
iShares Core DAX® | 1.454% | 0.904% | 16.592% | 16.557% |
iShares Nasdaq 100 | -0.913% | 3.463% | 36.062% | 50.205% |
iShares Nikkei 225® | 2.355% | 3.830% | 14.881% | 10.110% |
iShares S&P 500 | 0.283% | 2.639% | 29.599% | 44.509% |
Comments by Quitte for this prediction
In the thread Bayer AG diskutieren
allgemeine Erholung zur US-Wahl
und eine kleine Nachricht
IN KÜRZE-Bayer beantragt Zulassung für Regorafenib bei Leberkrebs